Daiichi Sankyo
Indu Bhargava is an experienced professional with a strong background in compliance monitoring, risk assessment, and IT audit. Currently serving as Associate Director at Daiichi Sankyo, Inc. since April 2018, Indu has overseen the implementation of OneTrust software for Data Privacy, managed the upgrade of the Enterprise Risk Management module, and implemented the SOX module for internal and external audit use. Indu also conducted JSOX assessments for both Daiichi Sankyo and ARI, and led the evaluation of various audit management tools. Prior to this role, Indu worked as a consultant in the Internal Audit Department at RGP and held various positions in IT audit and quality assurance at NYK Line, Avaya, PVH, and Merck, beginning a professional journey in 1998 at Efficient Solutions Inc. Educational credentials include studies at Virginia State University, Virginia Tech, and Allegheny College.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.